Abstract
A simple and sensitive red spectrofluorimetric method has been described for the estimation of hypocrellin B in rabbit plasma and ocular tissues such as retina, iris, aqueous humour and vitreous body. The fluorimetric estimation was achieved using black coloured 96- well plate at an excitation/emission wavelengths of 470/620 nm with a specific well volume of 100 µL/well. Hypocrellin B calibration curves were linear at a concentration ranging from 20 ng/mL to 1280 ng/mL with correlation coefficient between 0.86 and 0.99 in ocular tissues and plasma. Limit of detection and quantification was between 0.011 to 0.017 µg/mL and 0.034 to 0.054 g/mL respectively for hypocrellin B in different ocular tissues and plasma. The percentage relative standard deviation observed for the validation parameters such as method precision, system precision, intra- inter day, analyst to analyst variations and robustness is found to be less than 12.5 % for the observed fluorescence intensity in different ocular tissues/plasma. The method has been applied to check the hypocrellin B concentration in plasma and ocular tissues after intravenous administration and found that hypocrellin B has some exposure to the posterior segment of eye without major intraocular presuure abnormalities. This selective and sensitive fluorimetric method will facilitate the future investigations of hypocrellin B on ocular delivery of hypocrellin B with less solvent consumption.
Keywords: Calibration, emission, excitation, eye, fluorimetric, hypocrellin B.
Current Bioactive Compounds
Title:Quantification of Hypocrellin B in Rabbit Ocular Tissues/Plasma by Spectrofluorimeter: Application to Biodistribution Study
Volume: 10 Issue: 4
Author(s): Venkateshwaran Krishnaswami, Chandrasekar Ponnusamy, Senthilkumar Sankareswaran, Muthuselvam Paulsamy, Rajaguru Palanisamy and Subramanian Natesan
Affiliation:
Keywords: Calibration, emission, excitation, eye, fluorimetric, hypocrellin B.
Abstract: A simple and sensitive red spectrofluorimetric method has been described for the estimation of hypocrellin B in rabbit plasma and ocular tissues such as retina, iris, aqueous humour and vitreous body. The fluorimetric estimation was achieved using black coloured 96- well plate at an excitation/emission wavelengths of 470/620 nm with a specific well volume of 100 µL/well. Hypocrellin B calibration curves were linear at a concentration ranging from 20 ng/mL to 1280 ng/mL with correlation coefficient between 0.86 and 0.99 in ocular tissues and plasma. Limit of detection and quantification was between 0.011 to 0.017 µg/mL and 0.034 to 0.054 g/mL respectively for hypocrellin B in different ocular tissues and plasma. The percentage relative standard deviation observed for the validation parameters such as method precision, system precision, intra- inter day, analyst to analyst variations and robustness is found to be less than 12.5 % for the observed fluorescence intensity in different ocular tissues/plasma. The method has been applied to check the hypocrellin B concentration in plasma and ocular tissues after intravenous administration and found that hypocrellin B has some exposure to the posterior segment of eye without major intraocular presuure abnormalities. This selective and sensitive fluorimetric method will facilitate the future investigations of hypocrellin B on ocular delivery of hypocrellin B with less solvent consumption.
Export Options
About this article
Cite this article as:
Krishnaswami Venkateshwaran, Ponnusamy Chandrasekar, Sankareswaran Senthilkumar, Paulsamy Muthuselvam, Palanisamy Rajaguru and Natesan Subramanian, Quantification of Hypocrellin B in Rabbit Ocular Tissues/Plasma by Spectrofluorimeter: Application to Biodistribution Study, Current Bioactive Compounds 2014; 10 (4) . https://dx.doi.org/10.2174/1573407210666141001000336
DOI https://dx.doi.org/10.2174/1573407210666141001000336 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Onconeural Versus Paraneoplastic Antigens?
Current Medicinal Chemistry Beneficial Effects of Herbs, Spices and Medicinal Plants on the Metabolic Syndrome, Brain and Cognitive Function
Central Nervous System Agents in Medicinal Chemistry Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets The Role of Vascular Cell Senescence in Atherosclerosis: Antisenescence as a Novel Therapeutic Strategy for Vascular Aging
Current Vascular Pharmacology Rationally Designed Multitarget Agents Against Inflammation and Pain
Current Medicinal Chemistry Editorial (Thematic Issue: Therapies Targeting Oxidative Stress for Human Diseases: Where Are We Now?)
Current Pharmaceutical Biotechnology Mesenchymal Stem Cells and C-type Natriuretic Peptide Signaling: A Proposal for a New Treatment Approach for Skeletal Dysplasias
Current Stem Cell Research & Therapy Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews A Review on Rheumatoid Arthritis Interventions and Current Developments
Current Drug Targets Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design Sympathetic Overactivity in Hypertension and Cardiovascular Disease
Current Vascular Pharmacology Is There an Association between Periodontitis and Hypertension?
Current Cardiology Reviews Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence
Current Pharmaceutical Design Pigment Epithelium-Derived Factor (PEDF) Prevents Advanced Glycation End Products (AGEs)-Elicited Endothelial Nitric Oxide Synthase (eNOS) Reduction Through Its Anti-Oxidative Properties
Protein & Peptide Letters Lipid Lowering Drugs and Gallstones: A Therapeutic Option?
Current Pharmaceutical Design Immunoglobulin-G Glycation by Fructose Leads to Structural Perturbations and Drop Off in Free Lysine and Arginine Residues
Protein & Peptide Letters Vascular Injury During Elevated Glucose can be Mitigated by Erythropoietin and Wnt Signaling
Current Neurovascular Research Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis
Current Pharmaceutical Design The Role of Chinese Herbs and Acupuncture on the Inflammation Reaction After Cerebral Ischemia
Current Pharmaceutical Design Soybean and Processed Soy Foods Ingredients, and Their Role in Cardiometabolic Risk Prevention
Recent Patents on Food, Nutrition & Agriculture